{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:41:50Z","timestamp":1790901710197,"version":"4.1.0"},"reference-count":164,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IMI EU","award":["807015"],"award-info":[{"award-number":["807015"]}]},{"name":"IMI EU","award":["MAE00691612020-06-26"],"award-info":[{"award-number":["MAE00691612020-06-26"]}]},{"name":"IMI EU","award":["EURONANOMED2019-075"],"award-info":[{"award-number":["EURONANOMED2019-075"]}]},{"name":"IMI EU","award":["CP2_16\/2018"],"award-info":[{"award-number":["CP2_16\/2018"]}]},{"DOI":"10.13039\/501100006601","name":"Ministero degli Esteri e della Cooperazione Internazionale MAECI","doi-asserted-by":"publisher","award":["807015"],"award-info":[{"award-number":["807015"]}],"id":[{"id":"10.13039\/501100006601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006601","name":"Ministero degli Esteri e della Cooperazione Internazionale MAECI","doi-asserted-by":"publisher","award":["MAE00691612020-06-26"],"award-info":[{"award-number":["MAE00691612020-06-26"]}],"id":[{"id":"10.13039\/501100006601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006601","name":"Ministero degli Esteri e della Cooperazione Internazionale MAECI","doi-asserted-by":"publisher","award":["EURONANOMED2019-075"],"award-info":[{"award-number":["EURONANOMED2019-075"]}],"id":[{"id":"10.13039\/501100006601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006601","name":"Ministero degli Esteri e della Cooperazione Internazionale MAECI","doi-asserted-by":"publisher","award":["CP2_16\/2018"],"award-info":[{"award-number":["CP2_16\/2018"]}],"id":[{"id":"10.13039\/501100006601","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FAR Unimore Fondazione di Modena","award":["807015"],"award-info":[{"award-number":["807015"]}]},{"name":"FAR Unimore Fondazione di Modena","award":["MAE00691612020-06-26"],"award-info":[{"award-number":["MAE00691612020-06-26"]}]},{"name":"FAR Unimore Fondazione di Modena","award":["EURONANOMED2019-075"],"award-info":[{"award-number":["EURONANOMED2019-075"]}]},{"name":"FAR Unimore Fondazione di Modena","award":["CP2_16\/2018"],"award-info":[{"award-number":["CP2_16\/2018"]}]},{"name":"Creutzfeldt\u2013Jakob disease Foundation (CJDF)","award":["807015"],"award-info":[{"award-number":["807015"]}]},{"name":"Creutzfeldt\u2013Jakob disease Foundation (CJDF)","award":["MAE00691612020-06-26"],"award-info":[{"award-number":["MAE00691612020-06-26"]}]},{"name":"Creutzfeldt\u2013Jakob disease Foundation (CJDF)","award":["EURONANOMED2019-075"],"award-info":[{"award-number":["EURONANOMED2019-075"]}]},{"name":"Creutzfeldt\u2013Jakob disease Foundation (CJDF)","award":["CP2_16\/2018"],"award-info":[{"award-number":["CP2_16\/2018"]}]},{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["807015"],"award-info":[{"award-number":["807015"]}]},{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["MAE00691612020-06-26"],"award-info":[{"award-number":["MAE00691612020-06-26"]}]},{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["EURONANOMED2019-075"],"award-info":[{"award-number":["EURONANOMED2019-075"]}]},{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["CP2_16\/2018"],"award-info":[{"award-number":["CP2_16\/2018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glioblastoma multiforme (GBM) is the most common malignant brain tumor, associated with low long-term survival. Nanoparticles (NPs) developed against GBM are a promising strategy to improve current therapies, by enhancing the brain delivery of active molecules and reducing off-target effects. In particular, NPs hold high potential for the targeted delivery of chemotherapeutics both across the blood\u2013brain barrier (BBB) and specifically to GBM cell receptors, pathways, or the tumor microenvironment (TME). In this review, the most recent strategies to deliver drugs to GBM are explored. The main focus is on how surface functionalizations are essential for BBB crossing and for tumor specific targeting. We give a critical analysis of the various ligand-based approaches that have been used to target specific cancer cell receptors and the TME, or to interfere with the signaling pathways of GBM. Despite the increasing application of NPs in the clinical setting, new methods for ligand and surface characterization are needed to optimize the synthesis, as well as to predict their in vivo behavior. An expert opinion is given on the future of this research and what is still missing to create and characterize a functional NP system for improved GBM targeting.<\/jats:p>","DOI":"10.3390\/ijms24032496","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T04:58:25Z","timestamp":1675054705000},"page":"2496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-7565","authenticated-orcid":false,"given":"Francesca","family":"Rod\u00e0","sequence":"first","affiliation":[{"name":"Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy"},{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, 20148 Milan, Italy"},{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Caraffi","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy"},{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-0253","authenticated-orcid":false,"given":"Silvia","family":"Picciolini","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, 20148 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-667X","authenticated-orcid":false,"given":"Giovanni","family":"Tosi","sequence":"additional","affiliation":[{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Vandelli","sequence":"additional","affiliation":[{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ruozi","sequence":"additional","affiliation":[{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-3661","authenticated-orcid":false,"given":"Marzia","family":"Bedoni","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, 20148 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-2422","authenticated-orcid":false,"given":"Ilaria","family":"Ottonelli","sequence":"additional","affiliation":[{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2204-1981","authenticated-orcid":false,"given":"Jason Thomas","family":"Duskey","sequence":"additional","affiliation":[{"name":"Nanotech Lab, TE.FAR.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3322\/caac.21693","article-title":"Brain and Other Central Nervous System Tumor Statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and Molecular Epidemiology of Adult Diffuse Glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of Glioblastoma: State of the Art and Future Directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in Glioblastoma: A Review on the Impact of Treatment Modalities","volume":"18","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma Multiforme (GBM): An Overview of Current Therapies and Mechanisms of Resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.wneu.2018.04.022","article-title":"Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance","volume":"116","author":"Noch","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/BST20180444","article-title":"Glioblastoma Heterogeneity and the Tumour Microenvironment: Implications for Preclinical Research and Development of New Treatments","volume":"47","author":"Perrin","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","article-title":"Insights into Kinetics, Release, and Behavioral Effects of Brain-Targeted Hybrid Nanoparticles for Cholesterol Delivery in Huntington\u2019s Disease","volume":"330","author":"Birolini","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pederzoli, F., Ruozi, B., Duskey, J., Hagmeyer, S., Sauer, A.K., Grabrucker, S., Coelho, R., Oddone, N., Ottonelli, I., and Daini, E. (2019). Nanomedicine Against A\u03b2 Aggregation by \u03b2\u2013Sheet Breaker Peptide Delivery: In Vitro Evidence. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11110572"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Duskey, J.T., da Ros, F., Ottonelli, I., Zambelli, B., Vandelli, M.A., Tosi, G., and Ruozi, B. (2020). Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function. Molecules, 25.","DOI":"10.3390\/molecules25204593"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Duskey, J.T., Ottonelli, I., Rinaldi, A., Parmeggiani, I., Zambelli, B., Wang, L.Z., Prud\u2019homme, R.K., Vandelli, M.A., Tosi, G., and Ruozi, B. (2021). Tween\u00ae Preserves Enzyme Activity and Stability in PLGA Nanoparticles. Nanomaterials, 11.","DOI":"10.3390\/nano11112946"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/nnm-2019-0367","article-title":"Drug Delivery across the Blood\u2013Brain Barrier: Recent Advances in the Use of Nanocarriers","volume":"15","author":"Mulvihill","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rigon, L., Salvalaio, M., Pederzoli, F., Legnini, E., Duskey, J.T., D\u2019Avanzo, F., De Filippis, C., Ruozi, B., Marin, O., and Vandelli, M.A. (2019). Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20082014"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s11671-022-03668-6","article-title":"Nanoscale Drug Delivery Systems in Glioblastoma","volume":"17","author":"Liu","year":"2022","journal-title":"Nanoscale Res. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"119283","DOI":"10.1016\/j.ijpharm.2020.119283","article-title":"Glioblastoma Chemotherapeutic Agents Used in the Clinical Setting and in Clinical Trials: Nanomedicine Approaches to Improve Their Efficacy","volume":"581","author":"Lorenzoni","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120316","DOI":"10.1016\/j.jns.2022.120316","article-title":"The Brilliance of Nanoscience over Cancer Therapy: Novel Promising Nanotechnology-Based Methods for Eradicating Glioblastoma","volume":"440","author":"Shabani","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1570159X18666200831160627","article-title":"Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art","volume":"19","author":"Duarte","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_20","first-page":"1544","article-title":"An Update of Advanced Nanoplatforms for Glioblastoma Multiforme Management","volume":"20","author":"Amaral","year":"2021","journal-title":"EXCLI J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/IJN.S243223","article-title":"Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the Clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smaim.2020.04.001","article-title":"Nanoparticle-Based Drug Delivery Systems for Cancer Therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart Mater. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the Blood-Brain Tumor Barrier for Effective Glioblastoma Treatment","volume":"19","author":"Wesseling","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1039\/C4NR04853A","article-title":"Transferrin Receptor-Targeted Theranostic Gold Nanoparticles for Photosensitizer Delivery in Brain Tumors","volume":"7","author":"Dixit","year":"2015","journal-title":"Nanoscale"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the Insulin Receptor: Nanoparticles for Drug Delivery across the Blood\u2013Brain Barrier (BBB)","volume":"19","author":"Ulbrich","year":"2011","journal-title":"J. Drug Target."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1705668","DOI":"10.1002\/adfm.201705668","article-title":"Two-Step Targeted Hybrid Nanoconstructs Increase Brain Penetration and Efficacy of the Therapeutic Antibody Trastuzumab against Brain Metastasis of HER2-Positive Breast Cancer","volume":"28","author":"He","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/nn300240p","article-title":"Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood\u2013Brain Barrier","volume":"6","author":"Qiao","year":"2012","journal-title":"ACS Nano"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/anie.201411226","article-title":"A D-Peptide Ligand of Nicotine Acetylcholine Receptors for Brain-Targeted Drug Delivery","volume":"54","author":"Wei","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","article-title":"Nanoparticles of 2-Deoxy-d-Glucose Functionalized Poly(Ethylene Glycol)-Co-Poly(Trimethylene Carbonate) for Dual-Targeted Drug Delivery in Glioma Treatment","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1016\/j.biomaterials.2013.08.030","article-title":"Choline Transporter-Targeting and Co-Delivery System for Glioma Therapy","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1805697","DOI":"10.1002\/adma.201805697","article-title":"Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12951-019-0546-3","article-title":"The Synergistic Effect of Chlorotoxin-MApoE in Boosting Drug-Loaded Liposomes across the BBB","volume":"17","author":"Formicola","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","article-title":"Blood\u2013Brain Barrier Permeable Nano Immunoconjugates Induce Local Immune Responses for Glioma Therapy","volume":"10","author":"Galstyan","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Jnaidi, R., Almeida, A.J., and Gon\u00e7alves, L.M. (2020). Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090860"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1439","DOI":"10.1002\/wnan.1439","article-title":"Tumor-targeted Nanotherapeutics: Overcoming Treatment Barriers for Glioblastoma","volume":"9","author":"Wadajkar","year":"2017","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"120758","DOI":"10.1016\/j.ijpharm.2021.120758","article-title":"Highlights in Targeted Nanoparticles as a Delivery Strategy for Glioma Treatment","volume":"604","author":"Luiz","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2019.01.006","article-title":"Tumor Targeting Peptides: Novel Therapeutic Strategies in Glioblastoma","volume":"47","author":"Raucher","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41598-019-42643-7","article-title":"ITGA2 as a Potential Nanotherapeutic Target for Glioblastoma","volume":"9","author":"Guo","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Duskey, J.T., Rinaldi, A., Ottonelli, I., Caraffi, R., De Benedictis, C.A., Sauer, A.K., Tosi, G., Vandelli, M.A., Ruozi, B., and Grabrucker, A.M. (2022). Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071450"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1515\/revneuro-2013-0039","article-title":"Role of Caveolin-1 in the Biology of the Blood-Brain Barrier","volume":"25","author":"Zhao","year":"2014","journal-title":"Rev. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1039\/D0NH00077A","article-title":"A Brain Tumor-Homing Tetra-Peptide Delivers a Nano-Therapeutic for More Effective Treatment of a Mouse Model of Glioblastoma","volume":"5","author":"Kang","year":"2020","journal-title":"Nanoscale Horiz."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1021\/acsbiomaterials.1c00653","article-title":"A Deep Dive: SIWV Tetra-Peptide Enhancing the Penetration of Nanotherapeutics into the Glioblastoma","volume":"8","author":"Kang","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhao, R., Liu, J., Li, Z., Zhang, W., Wang, F., and Zhang, B. (2022). Recent Advances in CXCL12\/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081541"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jconrel.2022.10.047","article-title":"CXCR4-Targeted Nitric Oxide Nanoparticles Deliver PD-L1 SiRNA for Immunotherapy against Glioblastoma","volume":"352","author":"Hsieh","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.msec.2018.10.094","article-title":"Targeted Delivery of Etoposide, Carmustine and Doxorubicin to Human Glioblastoma Cells Using Methoxy Poly(Ethylene Glycol)-poly(\u0395-caprolactone) Nanoparticles Conjugated with Wheat Germ Agglutinin and Folic Acid","volume":"96","author":"Kuo","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2022.03.047","article-title":"All-Stage Targeted Therapy for Glioblastoma Based on Lipid Membrane Coated Cabazitaxel Nanocrystals","volume":"345","author":"Wu","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1803952","DOI":"10.1002\/smll.201803952","article-title":"From Supramolecular Vesicles to Micelles: Controllable Construction of Tumor-Targeting Nanocarriers Based on Host\u2013Guest Interaction between a Pillar[5]Arene-Based Prodrug and a RGD-Sulfonate Guest","volume":"14","author":"Hu","year":"2018","journal-title":"Small"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12951-021-01180-0","article-title":"Combined Integrin Av\u03b23 and Lactoferrin Receptor Targeted Docetaxel Liposomes Enhance the Brain Targeting Effect and Anti-Glioma Effect","volume":"19","author":"Qi","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"126296","DOI":"10.1016\/j.cej.2020.126296","article-title":"Stapled RAP12 Peptide Ligand of LRP1 for Micelles-Based Multifunctional Glioma-Targeted Drug Delivery","volume":"403","author":"Ruan","year":"2021","journal-title":"J. Chem. Eng."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101465","DOI":"10.1016\/j.nantod.2022.101465","article-title":"A D-Peptide Ligand of Neuropeptide Y Receptor Y1 Serves as Nanocarrier Traversing of the Blood Brain Barrier and Targets Glioma","volume":"44","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/1061186X.2021.1912053","article-title":"Efficient Antiglioblastoma Therapy in Mice through Doxorubicin-Loaded Nanomicelles Modified Using a Novel Brain-Targeted RVG-15 Peptide","volume":"29","author":"Han","year":"2021","journal-title":"J. Drug Target"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.2147\/IJN.S318266","article-title":"Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex","volume":"16","author":"Xin","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jconrel.2020.04.009","article-title":"\u03b1v\u03b23-Targeted Liposomal Drug Delivery System with Attenuated Immunogenicity Enabled by Linear Pentapeptide for Glioma Therapy","volume":"322","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"120305","DOI":"10.1016\/j.biomaterials.2020.120305","article-title":"Versatile Hollow COF Nanospheres via Manipulating Transferrin Corona for Precise Glioma-Targeted Drug Delivery","volume":"260","author":"Huo","year":"2020","journal-title":"Biomaterials"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"103366","DOI":"10.1016\/j.jddst.2022.103366","article-title":"Tumor Micro-Environment Targeted Collagenase-Modified Albumin Nanoparticles for Improved Drug Delivery","volume":"71","author":"Shukla","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"116009","DOI":"10.1016\/j.taap.2022.116009","article-title":"Epidermal Growth Factor-Labeled Liposomes as a Way to Target the Toxicity of Silver Nanoparticles into EGFR-Overexpressing Cancer Cells in Vitro","volume":"443","author":"Piechowiak","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"14887","DOI":"10.1021\/acsami.1c23274","article-title":"Dual-Targeting of Tumor Cells and Tumor-Associated Macrophages by Palmitic Acid Modified Albumin Nanoparticles for Antitumor and Antimetastasis Therapy","volume":"14","author":"Feng","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bioactmat.2021.12.029","article-title":"Biomimetic Nanoparticles Directly Remodel Immunosuppressive Microenvironment for Boosting Glioblastoma Immunotherapy","volume":"16","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.actbio.2022.06.041","article-title":"A Prodrug Hydrogel with Tumor Microenvironment and Near-Infrared Light Dual-Responsive Action for Synergistic Cancer Immunotherapy","volume":"149","author":"Ding","year":"2022","journal-title":"Acta Biomater."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.actbio.2021.11.017","article-title":"Binary Regulation of the Tumor Microenvironment by a PH-Responsive Reversible Shielding Nanoplatform for Improved Tumor Chemo-Immunotherapy","volume":"138","author":"Sun","year":"2022","journal-title":"Acta Biomater."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/ijc.33247","article-title":"Site-Specific Metastasis: A Cooperation between Cancer Cells and the Metastatic Microenvironment","volume":"148","author":"Izraely","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2002122","DOI":"10.1002\/adhm.202002122","article-title":"Microfluidic Reconstitution of Tumor Microenvironment for Nanomedical Applications","volume":"10","author":"Oh","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2100386","DOI":"10.1002\/adfm.202100386","article-title":"Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR Effect and beyond: Strategies to Improve Tumor Targeting and Cancer Nanomedicine Treatment Efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15170","DOI":"10.1002\/anie.201709002","article-title":"Editorial: Drug Delivery: Too Much Complexity, Not Enough Reproducibility","volume":"56","author":"Leroux","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To Exploit the Tumor Microenvironment: Since the EPR Effect Fails in the Clinic, What Is the Future of Nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41563-020-0669-9","article-title":"A Nanoparticle\u2019s Pathway into Tumours","volume":"19","author":"Mooney","year":"2020","journal-title":"Nat. Mater."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor Targeting via EPR: Strategies to Enhance Patient Responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.7150\/thno.37198","article-title":"Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2021.02.002","article-title":"Recent Advances in Tumor Microenvironment-Targeted Nanomedicine Delivery Approaches to Overcome Limitations of Immune Checkpoint Blockade-Based Immunotherapy","volume":"332","author":"Kim","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.apsb.2020.05.008","article-title":"Nanomedicine-Based Drug Delivery towards Tumor Biological and Immunological Microenvironment","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1061186X.2018.1455841","article-title":"RGD Peptide-Based Non-Viral Gene Delivery Vectors Targeting Integrin Av\u03b23 for Cancer Therapy","volume":"27","author":"Fu","year":"2019","journal-title":"J. Drug Target"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acsnano.7b08051","article-title":"Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9149","DOI":"10.1016\/j.biomaterials.2013.08.026","article-title":"In Vivo Fluorescence Imaging for Cancer Diagnosis Using Receptor-Targeted Epidermal Growth Factor-Based Nanoprobe","volume":"34","author":"Ryu","year":"2013","journal-title":"Biomaterials"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm.15.208","article-title":"EGF-Liposomes Promote Efficient EGFR Targeting in Xenograft Colocarcinoma Model","volume":"11","author":"Zalba","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mattod.2022.01.025","article-title":"Disabling Partners in Crime: Gold Nanoparticles Disrupt Multicellular Communications within the Tumor Microenvironment to Inhibit Ovarian Tumor Aggressiveness","volume":"56","author":"Zhang","year":"2022","journal-title":"Mater. Today"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2045-824X-3-26","article-title":"Nanoparticle Mediated Targeting of VEGFR and Cancer Stem Cells for Cancer Therapy","volume":"3","author":"Ambasta","year":"2011","journal-title":"Vasc. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e147276","DOI":"10.1172\/JCI147276","article-title":"Tumor Innervation: Peripheral Nerves Take Control of the Tumor Microenvironment","volume":"131","author":"Gysler","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2200046","DOI":"10.1002\/adbi.202200046","article-title":"The Role of Nerve Fibers in the Tumor Immune Microenvironment of Solid Tumors","volume":"6","author":"Hernandez","year":"2022","journal-title":"Adv. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic Nerves Activate an Angio-Metabolic Switch in Prostate Cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"120553","DOI":"10.1016\/j.ijpharm.2021.120553","article-title":"Sequential Receptor\u2013Mediated Mixed-Charge Nanomedicine to Target Pancreatic Cancer, Inducing Immunogenic Cell Death and Reshaping the Tumor Microenvironment","volume":"601","author":"Shen","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2014.01.032","article-title":"Hypoxia and Hypoxia Inducible Factors in Tumor Metabolism","volume":"356","author":"Zeng","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Rinaldi, A., Caraffi, R., Grazioli, M.V., Oddone, N., Giardino, L., Tosi, G., Vandelli, M.A., Calz\u00e0, L., Ruozi, B., and Duskey, J.T. (2022). Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines. Polymers, 14.","DOI":"10.3390\/polym14040687"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"118655","DOI":"10.1016\/j.ijpharm.2019.118655","article-title":"ROS-Responsive \u201cSmart\u201d Polymeric Conjugate: Synthesis, Characterization and Proof-of-Concept Study","volume":"570","author":"Oddone","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fphar.2020.00574","article-title":"Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment","volume":"11","author":"Oddone","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/acsomega.1c05815","article-title":"ES-MION-Based Dual-Modality PET\/MRI Probes for Acidic Tumor Microenvironment Imaging","volume":"7","author":"Wei","year":"2022","journal-title":"ACS Omega"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1021\/acsnano.1c09171","article-title":"Enhanced Chemodynamic Therapy by Cu\u2013Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction","volume":"16","author":"Koo","year":"2022","journal-title":"ACS Nano"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Malhotra, N., Lee, J.-S., Liman, R.A.D., Ruallo, J.M.S., Villaflores, O.B., Ger, T.-R., and Hsiao, C.-D. (2020). Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review. Molecules, 25.","DOI":"10.3390\/molecules25143159"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/s41598-018-19628-z","article-title":"Uptake, Distribution, Clearance, and Toxicity of Iron Oxide Nanoparticles with Different Sizes and Coatings","volume":"8","author":"Feng","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-Intrinsic Resistance to Immune Checkpoint Blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","article-title":"Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment","volume":"15","author":"Gao","year":"2021","journal-title":"ACS Nano"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2107550","DOI":"10.1002\/smll.202107550","article-title":"Targeted Nanoparticle for Co-Delivery of HER2 SiRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis","volume":"18","author":"Ngamcherdtrakul","year":"2022","journal-title":"Small"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e43653","DOI":"10.7554\/eLife.43653","article-title":"CCL5 Promotes Breast Cancer Recurrence through Macrophage Recruitment in Residual Tumors","volume":"8","author":"Walens","year":"2019","journal-title":"eLife"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2006220","DOI":"10.1002\/adfm.202006220","article-title":"Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of Response, Resistance, and Toxicity to Immune Checkpoint Blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond Immune Checkpoint Blockade: Emerging Immunological Strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1021\/acsnano.1c07492","article-title":"Systemic Delivery of an Adjuvant CXCR4\u2013CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy","volume":"16","author":"Alghamri","year":"2022","journal-title":"ACS Nano"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B Cell Regulation in Cancer and Anti-Tumor Immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2022.01.039","article-title":"Nano-Trapping CXCL13 Reduces Regulatory B Cells in Tumor Microenvironment and Inhibits Tumor Growth","volume":"343","author":"Shen","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1039\/C8NR02278J","article-title":"Characterization Techniques for Nanoparticles: Comparison and Complementarity upon Studying Nanoparticle Properties","volume":"10","author":"Mourdikoudis","year":"2018","journal-title":"Nanoscale"},{"key":"ref_103","unstructured":"Kaliva, M., and Vamvakaki, M. (2020). Polymer Science and Nanotechnology, Elsevier."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1901556","DOI":"10.1002\/adma.201901556","article-title":"Nanoparticle Characterization: What to Measure?","volume":"31","author":"Modena","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"050820","DOI":"10.1116\/1.4818423","article-title":"Surface Characterization of Nanomaterials and Nanoparticles: Important Needs and Challenging Opportunities","volume":"31","author":"Baer","year":"2013","journal-title":"J. Vac. Sci. Technol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of Surface Properties on Nanoparticle\u2013Cell Interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C6AN02206E","article-title":"Ligand Density Quantification on Colloidal Inorganic Nanoparticles","volume":"142","author":"Smith","year":"2017","journal-title":"Analyst"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/acs.analchem.0c05208","article-title":"Analytical Methods for Characterization of Nanomaterial Surfaces","volume":"93","author":"Jayawardena","year":"2021","journal-title":"Anal. Chem."},{"key":"ref_109","unstructured":"Kumar, A., and Dixit, C.K. (2017). Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids, Elsevier."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and Zeta Potential\u2014What They Are and What They Are Not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Silva, A.M., Martins-Gomes, C., Coutinho, T.E., Fangueiro, J.F., Sanchez-Lopez, E., Pashirova, T.N., Andreani, T., and Souto, E.B. (2019). Soft Cationic Nanoparticles for Drug Delivery: Production and Cytotoxicity of Solid Lipid Nanoparticles (SLNs). Appl. Sci., 9.","DOI":"10.3390\/app9204438"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ottonelli, I., Bighinati, A., Adani, E., Loll, F., Caraffi, R., Vandelli, M.A., Boury, F., Tosi, G., Duskey, J.T., and Marigo, V. (2023). Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010025"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2015.01.030","article-title":"Coating Nanocarriers with Hyaluronic Acid Facilitates Intravitreal Drug Delivery for Retinal Gene Therapy","volume":"202","author":"Martens","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1038\/s41467-020-17034-6","article-title":"Subsurface Chemical Nanoidentification by Nano-FTIR Spectroscopy","volume":"11","author":"Mester","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/10408347.2016.1157013","article-title":"FTIR Spectroscopy for Carbon Family Study","volume":"46","author":"Matei","year":"2016","journal-title":"Crit. Rev. Anal. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/05704928.2018.1426595","article-title":"FTIR Analysis of Natural and Synthetic Collagen","volume":"53","author":"Riaz","year":"2018","journal-title":"Appl. Spectrosc. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cjce.23664","article-title":"Experimental Methods in Chemical Engineering: Fourier Transform Infrared Spectroscopy\u2014FTIR","volume":"98","author":"Patience","year":"2020","journal-title":"Can. J. Chem. Eng."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2101701","DOI":"10.1002\/adma.202101701","article-title":"Sphingosine 1-Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors","volume":"33","author":"Liu","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1039\/D0BM01536A","article-title":"Development of Curcumin-Loaded Zein Nanoparticles for Transport across the Blood\u2013Brain Barrier and Inhibition of Glioblastoma Cell Growth","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejpb.2019.10.004","article-title":"Co-Encapsulation of Superparamagnetic Nanoparticles and Doxorubicin in PLGA Nanocarriers: Development, Characterization and in Vitro Antitumor Efficacy in Glioma Cells","volume":"145","author":"Sebastian","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10989-021-10229-5","article-title":"Structural Characterization and Drug Delivery System of Natural Growth-Modulating Peptide Against Glioblastoma Cancer","volume":"27","author":"Aslan","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Mazarei, M., Mohammadi Arvejeh, P., Mozafari, M.R., Khosravian, P., and Ghasemi, S. (2021). Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation. Nanomaterials, 11.","DOI":"10.3390\/nano11071704"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/rams-2021-0009","article-title":"Mesoporous Silica Nanoparticles Functionalized with Folic Acid for Targeted Release Cis-Pt to Glioblastoma Cells","volume":"60","author":"Tzompantzi","year":"2021","journal-title":"Rev. Adv. Mater. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Carissimi, G., Montalb\u00e1n, M.G., V\u00edllora, G., and Barth, A. (2020). Direct Quantification of Drug Loading Content in Polymeric Nanoparticles by Infrared Spectroscopy. Pharmaceutics, 12.","DOI":"10.20944\/preprints202009.0047.v1"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.04.003","article-title":"Raman Spectroscopy in Pharmaceutical Product Design","volume":"89","author":"Paudel","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"102097","DOI":"10.1016\/j.nano.2019.102097","article-title":"Raman Profiling of Circulating Extracellular Vesicles for the Stratification of Parkinson\u2019s Patients","volume":"22","author":"Gualerzi","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10404-008-0392-3","article-title":"Surface Enhanced Raman Spectroscopy and Its Application to Molecular and Cellular Analysis","volume":"6","author":"Huh","year":"2009","journal-title":"Microfluid Nanofluid"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1021\/acs.jmedchem.0c00694","article-title":"Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells","volume":"63","author":"Sahli","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Depciuch, J., Miszczyk, J., Maximenko, A., Zielinski, P.M., Rawoj\u0107, K., Panek, A., Olko, P., and Parlinska-Wojtan, M. (2020). Gold Nanopeanuts as Prospective Support for Cisplatin in Glioblastoma Nano-Chemo-Radiotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239082"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1021\/cm504809c","article-title":"NMR Techniques for Noble Metal Nanoparticles","volume":"27","author":"Marbella","year":"2015","journal-title":"Chem. Mater."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1021\/la049505j","article-title":"Application of NMR Spectroscopy to the Characterization of PEG-Stabilized Lipid Nanoparticles","volume":"20","author":"Torres","year":"2004","journal-title":"Langmuir"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1605895","DOI":"10.1002\/adma.201605895","article-title":"Understanding Surface and Interfacial Chemistry in Functional Nanomaterials via Solid-State NMR","volume":"29","author":"Marchetti","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"29037","DOI":"10.1021\/acsami.0c05556","article-title":"Hybrid Magnetic Nanovectors Promote Selective Glioblastoma Cell Death through a Combined Effect of Lysosomal Membrane Permeabilization and Chemotherapy","volume":"12","author":"Pucci","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Hoyos-Ceballos, G.P., Ruozi, B., Ottonelli, I., Da Ros, F., Vandelli, M.A., Forni, F., Daini, E., Vilella, A., Zoli, M., and Tosi, G. (2020). PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010072"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2019.01.010","article-title":"Tri-Block Copolymer Nanoparticles Modified with Folic Acid for Temozolomide Delivery in Glioblastoma","volume":"108","author":"Khoei","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2013.11.023","article-title":"Insight on the Fate of CNS-Targeted Nanoparticles. Part I: Rab5-Dependent Cell-Specific Uptake and Distribution","volume":"174","author":"Vilella","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"113649","DOI":"10.1016\/j.jpba.2020.113649","article-title":"An SPRi-Based Biosensor Pilot Study: Analysis of Multiple Circulating Extracellular Vesicles and Hippocampal Volume in Alzheimer\u2019s Disease","volume":"192","author":"Picciolini","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jconrel.2011.07.023","article-title":"An in Vitro Assay Based on Surface Plasmon Resonance to Predict the in Vivo Circulation Kinetics of Liposomes","volume":"156","author":"Crielaard","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.nano.2016.10.006","article-title":"Retro-Inverso Peptide Inhibitor Nanoparticles as Potent Inhibitors of Aggregation of the Alzheimer\u2019s A\u03b2 Peptide","volume":"13","author":"Gregori","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.2147\/IJN.S261352","article-title":"Multiscale Selectivity and in Vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma","volume":"15","author":"Gries","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Gabold, B., Adams, F., Brameyer, S., Jung, K., Ried, C.L., Merdan, T., and Merkel, O.M. (2022). Transferrin-Modified Chitosan Nanoparticles for Targeted Nose-to-Brain Delivery of Proteins. Drug Deliv. Transl. Res.","DOI":"10.1007\/s13346-022-01245-z"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"100332","DOI":"10.1016\/j.apsadv.2022.100332","article-title":"Review on Surface-Characterization Applications of X-Ray Photoelectron Spectroscopy (XPS): Recent Developments and Challenges","volume":"12","author":"Krishna","year":"2022","journal-title":"Appl. Surf. Sci. Adv."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Pulvirenti, L., Monforte, F., Lo Presti, F., Li Volti, G., Carota, G., Sinatra, F., Bongiorno, C., Mannino, G., Cambria, M.T., and Condorelli, G.G. (2022). Synthesis of MIL-Modified Fe3O4 Magnetic Nanoparticles for Enhancing Uptake and Efficiency of Temozolomide in Glioblastoma Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052874"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2100282","DOI":"10.1002\/ppsc.202100282","article-title":"Hydrophilic Gold Nanoparticles as Anti-PD-L1 Antibody Carriers: Synthesis and Interface Properties","volume":"39","author":"Venditti","year":"2022","journal-title":"Part. Part. Syst. Charact."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cjce.23673","article-title":"Experimental Methods in Chemical Engineering: Thermogravimetric Analysis\u2014TGA","volume":"98","author":"Saadatkhah","year":"2020","journal-title":"Can. J. Chem. Eng."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/ac402888v","article-title":"Determination of Nanoparticle Surface Coatings and Nanoparticle Purity Using Microscale Thermogravimetric Analysis","volume":"86","author":"Mansfield","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10973-020-09647-2","article-title":"Thermal Analysis of Carbon Nanomaterials: Advantages and Problems of Interpretation","volume":"142","author":"Bannov","year":"2020","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"\u015awi\u0119tek, M., Ma, Y.-H., Wu, N.-P., Paruzel, A., Tokarz, W., and Hor\u00e1k, D. (2022). Tannic Acid Coating Augments Glioblastoma Cellular Uptake of Magnetic Nanoparticles with Antioxidant Effects. Nanomaterials, 12.","DOI":"10.3390\/nano12081310"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.2147\/IJN.S206899","article-title":"Targeted Anticancer Potential against Glioma Cells of Thymoquinone Delivered by Mesoporous Silica Core-Shell Nanoformulations with PH-Dependent Release","volume":"14","author":"Shahein","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_150","unstructured":"Kirkland, A.I., and Haigh, S.J. (2015). Nanoscience & Nanotechnology Series, Royal Society of Chemistry."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1038\/srep09793","article-title":"Avoiding Drying-Artifacts in Transmission Electron Microscopy: Characterizing the Size and Colloidal State of Nanoparticles","volume":"5","author":"Michen","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ultramic.2017.07.001","article-title":"A Direct Comparison of Experimental Methods to Measure Dimensions of Synthetic Nanoparticles","volume":"182","author":"Eaton","year":"2017","journal-title":"Ultramicroscopy"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ghaferi, M., Raza, A., Koohi, M., Zahra, W., Akbarzadeh, A., Ebrahimi Shahmabadi, H., and Alavi, S.E. (2022). Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102183"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2209239","DOI":"10.1002\/adfm.202209239","article-title":"Brain-Targeting Metastatic Tumor Cell Membrane Cloaked Biomimetic Nanomedicines Mediate Potent Chemodynamic and RNAi Combinational Therapy of Glioblastoma","volume":"32","author":"Zhang","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Costagliola di Polidoro, A., Zambito, G., Haeck, J., Mezzanotte, L., Lamfers, M., Netti, P.A., and Torino, E. (2021). Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-CHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells. Cancers, 13.","DOI":"10.3390\/cancers13030503"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1021\/acsami.9b01107","article-title":"Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fchem.2019.00642","article-title":"Surface Study of Fe3O4 Nanoparticles Functionalized With Biocompatible Adsorbed Molecules","volume":"7","author":"Lesiak","year":"2019","journal-title":"Front. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Borowik, A., Butowska, K., Konkel, K., Banasiuk, R., Derewonko, N., Wyrzykowski, D., Davydenko, M., Cherepanov, V., Styopkin, V., and Prylutskyy, Y. (2019). The Impact of Surface Functionalization on the Biophysical Properties of Silver Nanoparticles. Nanomaterials, 9.","DOI":"10.3390\/nano9070973"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1038\/s41598-019-40769-2","article-title":"Gold-Decorated Magnetic Nanoparticles Design for Hyperthermia Applications and as a Potential Platform for Their Surface-Functionalization","volume":"9","author":"Sanz","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"109856","DOI":"10.1016\/j.msec.2019.109856","article-title":"Surface Chemistry of Gold Nanoparticles Determines Interactions with Bovine Serum Albumin","volume":"103","author":"Wang","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"120435","DOI":"10.1016\/j.lfs.2022.120435","article-title":"Transferrin-Modified Nanoparticles for Targeted Delivery of Asiatic Acid to Glioblastoma Cells","volume":"296","author":"Ramalho","year":"2022","journal-title":"Life Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/10837450.2018.1551901","article-title":"Preparation and Characterization of Angiopep-2 Functionalized Ginsenoside-Rg3 Loaded Nanoparticles and the Effect on C6 Glioma Cells","volume":"25","author":"Su","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-Targeted Codelivery of Bcl-2\/Bcl-Xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11095-021-03034-8","article-title":"Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: A Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules","volume":"38","author":"Gazaille","year":"2021","journal-title":"Pharm. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:17:31Z","timestamp":1760120251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":164,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032496"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032496","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]}}}